Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 501 - 550 out of 16,206

Document Document Title
WO/2021/049654A1
An organic electroluminescent element (1) which comprises a positive electrode (3), a negative electrode (4), a first light emitting layer (51) and a second light emitting layer (52) that is arranged between the first light emitting laye...  
WO/2021/049662A1
This organic electroluminescence element (1) includes a positive electrode (3), a negative electrode (4), a first light emitting layer (51), and a second light emitting layer (52) disposed between the first light emitting layer (51) and ...  
WO/2021/049663A1
An organic electroluminescence element (1) that has a positive electrode (3), a negative electrode (4), a first light-emitting layer (51), and a second light-emitting layer (52) that is arranged between the first light-emitting layer (51...  
WO/2021/050700A1
The present disclosure describes compounds of the formula: (I), (II), (III), (IV), (V). The compounds described herein may be cyclooxygenase (COX) (e.g., cyclooxygenase 2 (COX2)) inhibitors. The compounds may be radiolabeled. The compoun...  
WO/2021/042410A1
Disclosed are a selective butyrylcholinesterase inhibitor having general formula (I) or a pharmaceutically acceptable salt thereof, a preparation method therefor, and use thereof. By testing the efficacy of treatment of Alzheimer's disea...  
WO/2021/045207A1
The present invention relates to a production method for a highly reactive intermediate. The production method includes: preparing an electron-accepting active compound (1); preparing a piezoelectric material (3); and applying mechanical...  
WO/2021/039654A1
The present invention provides: an active-ray-sensitive or radiation-sensitive resin composition having a solid material concentration of 10% by mass or more, the active-ray-sensitive or radiation-sensitive resin composition comprising a...  
WO/2021/039824A1
An RNA methyltransferase inhibitor containing at least one type of compound selected from the group consisting of sulfonamide-based compounds represented by general formula (1) and pyrazoline-based compounds represented by general formul...  
WO/2021/032933A1
The present invention provides compounds of formula (I): Formula (I) compositions comprising such compounds; the use of such compounds in therapy; and methods of treating patients with such compounds; wherein A, Y, n, R1, R2A, R2B, R3 an...  
WO/2020/013696A9
The present invention pertains to novel thiocycloheptyne derivatives of general formula (I) : and in particular to thiacycloalkynesulfoimine derivatives and their synthesis. The invention also relates to the use of the novel thiocyclohep...  
WO/2021/030091A1
The present disclosure relates to compounds, compositions and supplements that are capable of treating obesity. The disclosure further relates to methods of treating obesity in a subject in need thereof.  
WO/2021/028810A1
The present invention relates to certain compounds, their use in therapy, as well as to pharmaceutical compositions including said compounds. Specifically, the invention relates to certain compounds and pharmaceutical compositions includ...  
WO/2021/027567A1
Provided is a combination of an EP4 receptor antagonist and a PD-1 inhibitor for treating cancer. Specifically, provided is a product combination comprising: (i) a first pharmaceutical composition comprising (a) a first active ingredient...  
WO/2021/025593A1
Components of bioluminescent systems are widely used reagents for multiple analyses including diagnostic systems, quality control systems, drug trial systems and the like. The present group of inventions discloses components of the biolu...  
WO/2021/023143A1
Disclosed are a synthetic scheme for a Relugolix intermediate and Relugolix. The synthetic scheme efficiently avoids the use of a highly toxic substance, i.e. methyl chloroformate or ethyl chloroformate, and uses other kinds of chlorofor...  
WO/2021/025448A1
The present invention relates to a novel compound that enables formation of an additional hydrogen bond with a specific amino acid position in histone acetyltransferase (HAT) p300 through the structural analysis of the HAT p300. The nove...  
WO/2021/019558A1
The present invention discloses an efficient process for synthesis of photosensitizer, 5-(3-pyridyl)-2,2'-bithiophene in high yield and purity.  
WO/2021/019559A1
Disclosed herein is a novel simple, short process for synthesis of the photosensitizer, 5-(3-pyridyl)-2,2'-bithiophene.  
WO/2021/018105A1
Provided are substituted pyrimidinedione compounds and uses thereof, as well as pharmaceutical compositions containing such compounds, which can be used as gonadotropin releasing hormone receptor antagonists. Provided are a method for pr...  
WO/2021/012014A1
The present invention relates to methods for preparing a variety of difluorohaloallylamine derivatives. The present invention also relates to novel difluorohaloallylamine derivatives that are capable of inhibiting certain amine oxidase e...  
WO/2021/012689A1
Disclosed herein are phenylthiophene sulfonamide compounds, pharmaceutical compositions, a preparation method therefor and use thereof. The compounds of the present invention are capable of effectively and selectively inhibiting Bcl-xL, ...  
WO/2021/016449A1
Disclosed herein are novel cycloalka[b]heteroaryl compounds having CX3CR1/ fractalkine receptor (CX3CR1) agonistic properties, pharmaceutical compositions comprising these compounds, chemical processes for preparing these compounds and t...  
WO/2021/015555A1
The present invention provides: a novel compound which can improve the luminous efficiency, stability, and service life of an element; an organic electric element using same; and an electronic device comprising the organic electric element.  
WO/2021/009566A1
Described herein are N-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl) carbamoyl)-4,5,6,7-tetrahydrobenzofuran-2-sulfonamide derivatives and related compounds of formula (I) wherein R1 is formulae (II), (III), (IV), (V), (VI), (VII), (VIII) or (...  
WO/2021/007661A1
The current application relates to cannabinoid derivatives of formula (I) and pharmaceutical compositions comprising the same. The cannabinoid derivative can be used for the treatment of diseases associated with cannabinoid receptor such...  
WO/2021/009567A1
Described herein are NLRP3 modulators and methods of utilizing NLRP3 modulators in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.  
WO/2021/001331A1
The present disclosure relates to substituted thiophene carboxamide derivatives of formula (I), their use for controlling phytopathogenic microorganisms and compositions comprising thereof.  
WO/2020/263989A1
Compounds that inhibit JNK, e.g., JNK2 and/or JNK3, such as fused thiophenes, and methods of making and using the compounds are provided.  
WO/2020/259078A1
Provided is a method for preparing an adamantyl-containing triphenylamine derivative, the method comprising first reacting an aryl halogenated adamantane or an aryl adamantane ester with a primary aromatic amine without separation or pur...  
WO/2020/262648A1
The present invention provides a compound that has an excellent pest-controlling effect and that is represented by formula (I) [in the formula, L represents an oxygen atom or CH2, E represents a C2-C10 chain hydrocarbon group or the like...  
WO/2020/262451A1
The invention addresses the problem that metal-organic frameworks have conventionally only been produced with terephthalic acids having a limited range of substituents even though the amount and type of gas stored thereby can vary depend...  
WO/2020/264176A1
Heteroaryl and aliphatic analogs of diarylurea-based cannabinoid 1 receptor (CB1 R) allosteric modulators of formula (I) are described. Exemplary analogs can provide improved potencies and pharmacokinetic properties. Methods of using the...  
WO/2020/262507A1
Provided are a compound that further improves the performance of an organic EL element, an organic electroluminescence element having improved element performance, and an electronic device including such an organic electroluminescence el...  
WO/2020/262134A1
The present invention addresses the problem of providing a purification method for an actinic ray-sensitive or radiation-sensitive resin composition which can be used to form a pattern in which defects are inhibited. The present inventio...  
WO/2020/253445A1
Provided are an organic electroluminescent material and an organic luminescent device comprising the organic electroluminescent material. The organic electroluminescent material has the structural formula of (I). Compared with a monoamin...  
WO/2020/255964A1
Provided is an actinic ray-sensitive or radiation-sensitive resin composition by which a pattern having excellent LWR performance can be formed. Provided are: a resist film and a pattern forming method which use the actinic ray-sensitive...  
WO/2020/253283A1
Provided in the present invention is a novel diaroyl carbazole compound, used together with a carbazolyl oxime ester photoinitiator to show a significant synergistic initiation effect in a photoresist composition; the best sensitising ef...  
WO/2020/252628A1
Oxime ester compounds represented by formulas (I) and (II) containing an unsaturated five-membered heteroaromatic ring structure, wherein m, n, n', A1, A2, R1, R2, R3, R4, R5, R6, R6', R7, and R7' are defined in the specification. The co...  
WO/2020/250223A1
The invention relates to a novel substituted amino acids, agricultural compositions comprising the novel substituted amino acids, and their use for controlling undesired plant growth alone or in combination with crop protection agents su...  
WO/2020/252456A1
Various embodiments relate to compounds, having structures according to Structure A or Structure B, as specified herein. The compounds according to various embodiments may inhibit NT5C2 nucleotidase. The compounds according to various em...  
WO/2020/248755A1
Disclosed are a nitrogen-containing compound, an organic electroluminescent device and a photoelectric conversion device, belonging to the technical field of electronic components. The structure of the nitrogen-containing compound is as ...  
WO/2020/248943A1
The present application provides a nitrogen-containing compound, an electronic component and an electronic device, and belongs to the technical field of organic materials. The structure of the nitrogen-containing compound is as shown in ...  
WO/2020/250880A1
The present invention addresses the problem of providing a compound having high photobase generation efficiency. The present invention is a carbamoyl oxime compound represented by general formula (I). In the formula, R1, R2, R3, R4, R5, ...  
WO/2020/244323A1
Disclosed are a preparation method for a cis-p-mentha-1,8-secondary amine compound and a herbicidal application thereof. The method comprises: using a cis-p-mentha-1,8-di-schiff base compound as a raw material, putting reducing agents in...  
WO/2020/240178A1
A compound, e.g. a diamine ligand, represented by the following general formula (1): (Formula (1)) wherein each * represents an asymmetric carbon atom; X represents a group selected from one of an ester (e.g. a t-butyl ester); a thioeste...  
WO/2020/238862A1
The present invention provides a fluorene initiator, a photocurable composition comprising same, and an application thereof. The fluorene photoinitiator has a structure represented by formula (I) or formula (II). In the photoinitiator, o...  
WO/2020/232742A1
Provided is a bifenthrin derivative, wherein same has a structural formula as shown in formula (I). The derivative is obtained mainly through modifying and transforming benzene rings at the ortho-position and terminal-position on an inte...  
WO/2020/185054A9
The present invention provides a novel compound and an organic light emitting device using same.  
WO/2020/225569A1
The present invention relates to a compound of formula (I), or a pharmaceutically acceptable salt or hydrate thereof, wherein: the group X-Y is -NHSO2- or -SO2NH-; Z is a monocyclic aryl or heteroaryl group, each of which is optionally s...  
WO/2020/220942A1
A compound, an organic electroluminescent device containing the compound, and an application thereof. The compound has a structure shown in (I).  

Matches 501 - 550 out of 16,206